Exchange: NASDAQ·Updated 07:52 PM EST

About OMER

About

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
175

Frequently Asked Questions

Advertisement|Remove ads.